Please try another search
Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers automatic detection instruments, including coagulation, hemorheology, hematocrit, and platelet aggregation, as well as supporting reagents and consumables. Its products are used in the prevention, screening, diagnosis, and monitoring of thrombophilia, coronary heart disease, venous thromboembolism, and other thrombotic and bleeding diseases. Beijing Succeeder Technology Inc. was founded in 2003 and is based in Beijing, China.
Name | Age | Since | Title |
---|---|---|---|
Shiming Wu | 66 | 2015 | Chairman |
Pelin Mu | 57 | 2022 | Independent Director |
Tong Wu | 39 | 2022 | Director |
Ying Zhang | 51 | 2022 | Chairman of the Supervisory Board |
Yuk Wong | 45 | 2015 | Employee Representative Supervisor |
Hai Wang | 53 | 2020 | GM & Director |
Guo Li | 47 | 2016 | Financial Director & Director |
Zhonghui Ding | 51 | 2015 | Deputy GM & Director |
Xiaofeng Gu | 53 | 2015 | Deputy GM & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review